Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Acer Therapeutics, NCATS partner to develop emetine for Covid-19

pharmaceutical-technologyMay 14, 2020

Tag: Acer Therapeutics , NCATS , COVID-19 , emetine

PharmaSources Customer Service